LOGC

ContextLogic Holdings Inc.CIK 2064307 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for LOGC PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for LOGC

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Stewart Scott Matthew	CFO & COO	2	$97.6K	$0	2026-06-12
LEVY PAUL S	Director	6	$1.25M	$0	2026-06-08
Bobbili Raja	Director, 10% Owner	13	$17.57M	$0	2026-05-28
Chou Jennifer Kwon	Director	4	$0	$0	2026-03-31
Riva Capital Partners V, L.P.	10% Owner	1	$12.31M	$0	2026-02-26
Abrams David C	Director, 10% Owner	1	$12.31M	$0	2026-02-26
Farlekas Michael	Director	9	$0	$0	2026-01-15
Heinberg Marshall S	Director	9	$0	$0	2026-01-15
Scarola Michael Gerard	Chief Financial Officer	5	$0	$0	2025-11-19
Just Brett	Chief Financial Officer	12	$0	$0	2025-05-16
Bajaj Rishi	Chief Executive Officer	3	$0	$0	2025-05-07
LaPuma Elizabeth A.	Director	2	$0	$0	2025-01-15
PARISI RICHARD S	Director	2	$0	$0	2025-01-15
Forster Joanna	General Counsel & CCO	3	$0	$0	2024-07-01
Kahn Susan	Director	3	$0	$0	2022-11-16
Gruskin Daniel	Chief Medical Officer	7	$0	$6.4K	2022-11-16
Nacht Mariana	Chief Scientific Officer	3	$0	$0	2022-11-16
Karydas Daphne	Director	4	$0	$0	2022-11-16
Kay Mark A	Director	13	$0	$0	2022-11-16
Chen Leon	Director	11	$0	$0	2022-11-16
Goater Jeff	Director	4	$0	$0	2022-11-16
Chereau Frederic	President, CEO	12	$0	$43.2K	2022-11-16
Enyedy Mark J	Director	8	$0	$0	2022-11-16
WYZGA MICHAEL S	Director	10	$0	$0	2022-11-16
MOSCICKI RICHARD A	Director	10	$0	$0	2022-11-16
Paul Andrea	General Counsel and Secretary	2	$0	$0	2022-03-01
Jones Cecilia	Chief Financial Officer	7	$0	$0	2022-03-01
Chiang Kyle	Chief Operating Officer	5	$0	$17.1K	2021-04-16
O'Connell Daniel P	Director	9	$7.00M	$0	2020-12-10
Chimovits Erez	Director, 10% Owner	11	$13.79M	$0	2020-10-01
ORBIMED ADVISORS LLC	Director, 10% Owner	3	$8.89M	$0	2020-10-01
Arix Bioscience Holdings Ltd	10% Owner	10	$0	$4.60M	2020-09-28
Yoon Seokho Bryan	Chief Admin Officer & GC	3	$0	$0	2020-04-15
Jaffe Matthias	Chief Financial Officer	4	$0	$0	2020-04-15
Huttner Kenneth	SVP, Head of Clinical Dev.	2	$0	$0	2020-02-11
Kariv Tomer	Director	11	$4.20M	$0	2019-12-19
Wilton Thomas	Chief Business Officer	4	$0	$0	2019-08-27
Ioannidou Sofia	Director	4	$4.20M	$0	2018-10-23
Arix Bioscience plc	10% Owner	3	$7.00M	$0	2018-10-23
OrbiMed Israel GP II, L.P.	Director, 10% Owner	7	$11.90M	$0	2018-10-23
Falb Dean	Chief Scientific Officer	2	$0	$0	2018-10-18
Poole Sandra	Chief Operating Officer	2	$0	$0	2018-10-18
FARKAS HOWARD L	Director, 10% Owner	16	$327.1K	$0	2013-04-04
Stanley Robert	Director, 10% Owner	6	$240.0K	$0	2012-05-14

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Stewart Scott Matthew	CFO & COO	P Buy	2026-06-12	2026-06-15	10,000	$9.76	$97.6K	60,000	SEC↗
LEVY PAUL S	Director	P Buy	2026-06-08	2026-06-10	12,926	$9.17	$118.5K	638,112	SEC↗
LEVY PAUL S	Director	P Buy	2026-06-05	2026-06-05	63,019	$9.06	$571.0K	625,186	SEC↗
LEVY PAUL S	Director	P Buy	2026-06-04	2026-06-05	1,000	$9.04	$9.0K	562,167	SEC↗
LEVY PAUL S	Director	P Buy	2026-06-03	2026-06-05	35,409	$9.02	$319.4K	561,167	SEC↗
LEVY PAUL S	Director	P Buy	2026-06-02	2026-06-03	18,981	$9.05	$171.8K	525,758	SEC↗
Stewart Scott Matthew	CFO & COO	A Award deriv	2026-06-01	2026-06-03	50,000	—	$0	50,000	SEC↗
LEVY PAUL S	Director	P Buy	2026-06-01	2026-06-03	6,712	$9.02	$60.5K	506,777	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-05-28	2026-05-28	92,918	$8.75	$813.0K	630,201	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-05-27	2026-05-28	4,862	$8.75	$42.5K	537,283	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-05-26	2026-05-28	32,421	$8.63	$279.8K	532,421	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-05-21	2026-05-21	45,430	$8.69	$394.8K	500,000	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-05-20	2026-05-21	87,295	$8.77	$765.6K	454,570	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-05-19	2026-05-21	17,275	$8.74	$151.0K	367,275	SEC↗
Chou Jennifer K	Director	M Exercise deriv	2026-03-31	2026-04-01	56,701	—	$0	19,206	SEC↗
Chou Jennifer K	Director	M Exercise	2026-03-31	2026-04-01	56,701	—	$0	56,701	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-03-17	2026-03-19	29,000	$8.60	$249.4K	350,000	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-03-16	2026-03-16	29,271	$8.34	$244.1K	321,000	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-03-13	2026-03-16	35,229	$8.20	$288.9K	291,729	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-03-12	2026-03-16	6,500	$8.00	$52.0K	256,500	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-03-10	2026-03-11	87,366	$7.90	$690.2K	250,000	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-03-09	2026-03-11	162,634	$7.92	$1.29M	162,634	SEC↗
Abrams David C	Director, 10% Owner	P Buy	2026-02-26	2026-02-26	1,758,794	$7.00	$12.31M	18,269,534	SEC↗
Riva Capital Partners V, L.P.	10% Owner	P Buy	2026-02-26	2026-02-26	1,758,794	$7.00	$12.31M	18,269,534	SEC↗
Bobbili Raja	Director, 10% Owner	P Buy	2026-02-26	2026-02-26	1,758,794	$7.00	$12.31M	18,269,534	SEC↗
Farlekas Michael	Director	M Exercise deriv	2026-01-15	2026-01-20	20,775	—	$0	0	SEC↗
Farlekas Michael	Director	A Award deriv	2026-01-15	2026-01-20	19,206	—	$0	19,206	SEC↗
Heinberg Marshall S	Director	A Award deriv	2026-01-15	2026-01-20	19,206	—	$0	19,206	SEC↗
Heinberg Marshall S	Director	M Exercise deriv	2026-01-15	2026-01-20	44,321	—	$0	0	SEC↗
Chou Jennifer Kwon	Director	A Award deriv	2026-01-15	2026-01-20	19,206	—	$0	75,907	SEC↗
Farlekas Michael	Director	M Exercise	2026-01-15	2026-01-20	20,775	—	$0	111,260	SEC↗
Heinberg Marshall S	Director	M Exercise	2026-01-15	2026-01-20	44,321	—	$0	134,806	SEC↗
Farlekas Michael	Director	M Exercise deriv	2025-12-05	2025-12-08	64,801	—	$0	0	SEC↗
Heinberg Marshall S	Director	M Exercise deriv	2025-12-05	2025-12-08	64,801	—	$0	0	SEC↗
Farlekas Michael	Director	M Exercise	2025-12-05	2025-12-08	64,801	—	$0	90,485	SEC↗
Heinberg Marshall S	Director	M Exercise	2025-12-05	2025-12-08	64,801	—	$0	90,485	SEC↗
Scarola Michael Gerard	Chief Financial Officer	F Tax w/h	2025-11-19	2025-11-20	4,485	$7.05	$31.6K	7,385	SEC↗
Scarola Michael Gerard	Chief Financial Officer	M Exercise deriv	2025-11-14	2025-11-18	11,870	—	$0	11,870	SEC↗
Scarola Michael Gerard	Chief Financial Officer	M Exercise deriv	2025-11-14	2025-11-20	11,870	—	$0	11,870	SEC↗
Scarola Michael Gerard	Chief Financial Officer	M Exercise	2025-11-14	2025-11-18	11,870	—	$0	11,870	SEC↗
Scarola Michael Gerard	Chief Financial Officer	A Award deriv	2025-06-30	2025-07-02	23,740	—	$0	23,740	SEC↗
Just Brett	Chief Financial Officer	F Tax w/h	2025-05-16	2025-05-19	3,301	$7.41	$24.5K	29,349	SEC↗
Just Brett	Chief Financial Officer	M Exercise deriv	2025-05-15	2025-05-19	6,466	—	$0	0	SEC↗
Just Brett	Chief Financial Officer	M Exercise	2025-05-15	2025-05-19	6,466	—	$0	32,650	SEC↗
Bajaj Rishi	Chief Executive Officer	F Tax w/h	2025-05-07	2025-05-08	24,722	$6.95	$171.8K	51,134	SEC↗
Bajaj Rishi	Chief Executive Officer	M Exercise deriv	2025-05-06	2025-05-08	55,856	—	$0	0	SEC↗
Bajaj Rishi	Chief Executive Officer	M Exercise	2025-05-06	2025-05-08	55,856	—	$0	75,856	SEC↗
Farlekas Michael	Director	M Exercise deriv	2025-04-19	2025-04-21	25,684	—	$0	0	SEC↗
Heinberg Marshall	Director	M Exercise deriv	2025-04-19	2025-04-21	25,684	—	$0	0	SEC↗
Farlekas Michael	Director	M Exercise	2025-04-19	2025-04-21	25,684	—	$0	25,684	SEC↗
Heinberg Marshall	Director	M Exercise	2025-04-19	2025-04-21	25,684	—	$0	25,684	SEC↗
Chou Jennifer Kwon	Director	A Award deriv	2025-03-31	2025-04-02	56,701	—	$0	56,701	SEC↗
Just Brett	Chief Financial Officer	F Tax w/h	2025-02-18	2025-02-19	3,288	$7.88	$25.9K	26,184	SEC↗
Just Brett	Chief Financial Officer	M Exercise deriv	2025-02-15	2025-02-19	6,465	—	$0	6,466	SEC↗
Just Brett	Chief Financial Officer	M Exercise	2025-02-15	2025-02-19	6,465	—	$0	29,472	SEC↗
Heinberg Marshall	Director	A Award deriv	2025-01-15	2025-01-17	44,321	—	$0	44,321	SEC↗
PARISI RICHARD S	Director	A Award deriv	2025-01-15	2025-01-17	45,360	—	$0	45,360	SEC↗
Farlekas Michael	Director	A Award deriv	2025-01-15	2025-01-17	20,775	—	$0	20,775	SEC↗
LaPuma Elizabeth A.	Director	A Award deriv	2025-01-15	2025-01-17	20,775	—	$0	20,775	SEC↗
Farlekas Michael	Director	A Award deriv	2024-12-06	2024-12-09	64,801	—	$0	90,485	SEC↗
LaPuma Elizabeth A.	Director	A Award deriv	2024-12-06	2024-12-09	64,801	—	$0	90,485	SEC↗
Heinberg Marshall	Director	A Award deriv	2024-12-06	2024-12-09	64,801	—	$0	90,485	SEC↗
PARISI RICHARD S	Director	A Award deriv	2024-12-06	2024-12-09	64,801	—	$0	90,485	SEC↗
Just Brett	Chief Financial Officer	F Tax w/h	2024-11-18	2024-11-19	3,317	$6.31	$20.9K	23,007	SEC↗
Just Brett	Chief Financial Officer	M Exercise deriv	2024-11-15	2024-11-19	6,466	—	$0	12,931	SEC↗
Just Brett	Chief Financial Officer	M Exercise	2024-11-15	2024-11-19	6,466	—	$0	26,324	SEC↗
Just Brett	Chief Financial Officer	F Tax w/h	2024-08-16	2024-08-19	3,308	$5.42	$17.9K	19,858	SEC↗
Just Brett	Chief Financial Officer	M Exercise deriv	2024-08-15	2024-08-19	6,465	—	$0	19,397	SEC↗
Just Brett	Chief Financial Officer	M Exercise	2024-08-15	2024-08-19	6,465	—	$0	23,166	SEC↗
Forster Joanna	General Counsel & CCO	F Tax w/h	2024-07-01	2024-07-02	32,635	$5.59	$182.4K	59,520	SEC↗
Forster Joanna	General Counsel & CCO	M Exercise deriv	2024-06-28	2024-07-02	63,063	—	$0	0	SEC↗
Forster Joanna	General Counsel & CCO	M Exercise	2024-06-28	2024-07-02	63,063	—	$0	92,155	SEC↗
Kahn Susan	Director	D To issuer deriv	2022-11-16	2022-11-17	12,500	—	$0	0	SEC↗
Gruskin Daniel	Chief Medical Officer	D To issuer deriv	2022-11-16	2022-11-17	140,000	—	$0	0	SEC↗
Chen Leon	Director	D To issuer deriv	2022-11-16	2022-11-17	12,500	—	$0	0	SEC↗
Chen Leon	Director	D To issuer deriv	2022-11-16	2022-11-17	44,508	—	$0	0	SEC↗
Karydas Daphne	Director	D To issuer deriv	2022-11-16	2022-11-17	12,500	—	$0	0	SEC↗
Goater Jeff	Director	D To issuer deriv	2022-11-16	2022-11-17	12,500	—	$0	0	SEC↗
MOSCICKI RICHARD A	Director	D To issuer deriv	2022-11-16	2022-11-17	12,500	—	$0	0	SEC↗
Chereau Frederic	President, CEO	D To issuer deriv	2022-11-16	2022-11-17	328,000	—	$0	0	SEC↗
Chereau Frederic	President, CEO	D To issuer deriv	2022-11-16	2022-11-17	547,000	—	$0	0	SEC↗
WYZGA MICHAEL S	Director	D To issuer deriv	2022-11-16	2022-11-17	12,500	—	$0	0	SEC↗
Nacht Mariana	Chief Scientific Officer	D To issuer deriv	2022-11-16	2022-11-17	100,000	—	$0	0	SEC↗
Enyedy Mark J	Director	D To issuer deriv	2022-11-16	2022-11-17	12,500	—	$0	0	SEC↗
Kay Mark A	Director	D To issuer deriv	2022-11-16	2022-11-17	12,500	—	$0	0	SEC↗
Kay Mark A	Director	D To issuer deriv	2022-11-16	2022-11-17	140,615	—	$0	0	SEC↗
Kay Mark A	Director	D To issuer deriv	2022-11-16	2022-11-17	13,089	—	$0	0	SEC↗
Gruskin Daniel	Chief Medical Officer	D To issuer	2022-11-16	2022-11-17	3,331	—	$0	0	SEC↗
Chen Leon	Director	D To issuer	2022-11-16	2022-11-17	22,333	—	$0	0	SEC↗
MOSCICKI RICHARD A	Director	D To issuer	2022-11-16	2022-11-17	3,916	—	$0	0	SEC↗
Chereau Frederic	President, CEO	D To issuer	2022-11-16	2022-11-17	253,811	—	$0	0	SEC↗
WYZGA MICHAEL S	Director	D To issuer	2022-11-16	2022-11-17	3,141	—	$0	0	SEC↗
Enyedy Mark J	Director	D To issuer	2022-11-16	2022-11-17	2,921	—	$0	0	SEC↗
Kay Mark A	Director	D To issuer	2022-11-16	2022-11-17	784,557	—	$0	0	SEC↗
Karydas Daphne	Director	A Award deriv	2022-06-17	2022-07-05	12,500	—	$0	12,500	SEC↗
MOSCICKI RICHARD A	Director	A Award deriv	2022-06-17	2022-06-21	12,500	—	$0	12,500	SEC↗
Chen Leon	Director	A Award deriv	2022-06-17	2022-06-21	12,500	—	$0	12,500	SEC↗
Enyedy Mark J	Director	A Award deriv	2022-06-17	2022-06-21	12,500	—	$0	12,500	SEC↗
Goater Jeff	Director	A Award deriv	2022-06-17	2022-06-21	12,500	—	$0	12,500	SEC↗
Kahn Susan	Director	A Award deriv	2022-06-17	2022-06-21	12,500	—	$0	12,500	SEC↗
Kay Mark A	Director	A Award deriv	2022-06-17	2022-06-21	12,500	—	$0	12,500	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2022-06-17	2022-06-21	12,500	—	$0	12,500	SEC↗
Chereau Frederic	President and Chief Executiv	A Award deriv	2022-03-01	2022-03-03	328,000	—	$0	328,000	SEC↗
Nacht Mariana	Chief Scientific Officer	A Award deriv	2022-03-01	2022-03-03	100,000	—	$0	100,000	SEC↗
Jones Cecilia	Chief Financial Officer	A Award deriv	2022-03-01	2022-03-03	112,000	—	$0	112,000	SEC↗
Gruskin Daniel	Chief Medical Officer	A Award deriv	2022-03-01	2022-03-03	140,000	—	$0	140,000	SEC↗
Paul Andrea	General Counsel and Secretar	A Award deriv	2022-03-01	2022-03-03	80,000	—	$0	80,000	SEC↗
Jones Cecilia	Chief Financial Officer	F Tax w/h	2022-01-12	2022-01-13	2,175	$2.01	$4.4K	3,764	SEC↗
Jones Cecilia	Chief Financial Officer	M Exercise deriv	2022-01-11	2022-01-13	5,939	—	$0	0	SEC↗
Jones Cecilia	Chief Financial Officer	M Exercise	2022-01-11	2022-01-13	5,939	—	$0	5,939	SEC↗
Kahn Susan	Director	A Award deriv	2021-12-21	2021-12-23	25,000	—	$0	25,000	SEC↗
Gruskin Daniel	Chief Medical Officer	S Sale	2021-08-09	2021-08-10	1,467	$4.35	$6.4K	3,331	SEC↗
Gruskin Daniel	Chief Medical Officer	M Exercise deriv	2021-08-06	2021-08-10	4,798	—	$0	0	SEC↗
Gruskin Daniel	Chief Medical Officer	M Exercise	2021-08-06	2021-08-10	4,798	—	$0	4,798	SEC↗
Kay Mark A	Director	A Award deriv	2021-06-18	2021-06-21	5,000	—	$0	5,000	SEC↗
MOSCICKI RICHARD A	Director	A Award deriv	2021-06-11	2021-06-14	12,500	—	$0	12,500	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2021-06-11	2021-06-14	12,500	—	$0	12,500	SEC↗
Karydas Daphne	Director	A Award deriv	2021-06-11	2021-06-14	12,500	—	$0	12,500	SEC↗
Chen Leon	Director	A Award deriv	2021-06-11	2021-06-14	12,500	—	$0	12,500	SEC↗
Goater Jeff	Director	A Award deriv	2021-06-11	2021-06-14	12,500	—	$0	12,500	SEC↗
Enyedy Mark J	Director	A Award deriv	2021-06-11	2021-06-14	12,500	—	$0	12,500	SEC↗
Kay Mark A	Director	A Award deriv	2021-06-11	2021-06-14	12,500	—	$0	12,500	SEC↗
Gruskin Daniel	Chief Medical Officer	A Award deriv	2021-05-19	2021-05-20	60,000	—	$0	60,000	SEC↗
Paul Andrea	General Counsel and Secretar	A Award deriv	2021-05-17	2021-05-19	165,000	—	$0	165,000	SEC↗
Chereau Frederic	President and Chief Executiv	S Sale	2021-04-16	2021-04-19	7,542	$5.73	$43.2K	253,811	SEC↗
Chiang Kyle	Chief Operating Officer	S Sale	2021-04-16	2021-04-19	2,977	$5.73	$17.1K	23,387	SEC↗
Chereau Frederic	President and Chief Executiv	M Exercise deriv	2021-04-15	2021-04-19	23,414	—	$0	0	SEC↗
Chiang Kyle	Chief Operating Officer	M Exercise deriv	2021-04-15	2021-04-19	9,360	—	$0	0	SEC↗
Chereau Frederic	President and Chief Executiv	M Exercise	2021-04-15	2021-04-19	23,414	—	$0	261,353	SEC↗
Chiang Kyle	Chief Operating Officer	M Exercise	2021-04-15	2021-04-19	9,360	—	$0	26,364	SEC↗
Jones Cecilia	Chief Financial Officer	A Award deriv	2021-02-23	2021-02-25	78,000	—	$0	78,000	SEC↗
Chereau Frederic	President and Chief Executiv	A Award deriv	2021-02-23	2021-02-25	282,804	—	$0	282,804	SEC↗
Chiang Kyle	Chief Operating Officer	A Award deriv	2021-02-23	2021-02-25	155,701	—	$0	155,701	SEC↗
Jones Cecilia	Chief Financial Officer	A Award deriv	2021-01-11	2021-01-13	5,939	—	$0	5,939	SEC↗
Jones Cecilia	Chief Financial Officer	A Award deriv	2021-01-11	2021-01-13	195,000	—	$0	195,000	SEC↗
MOSCICKI RICHARD A	Director	M Exercise deriv	2021-01-01	2021-01-04	3,916	—	$0	0	SEC↗
WYZGA MICHAEL S	Director	M Exercise deriv	2021-01-01	2021-01-04	3,141	—	$0	0	SEC↗
Enyedy Mark J	Director	M Exercise deriv	2021-01-01	2021-01-04	2,921	—	$0	0	SEC↗
	Director	M Exercise deriv	2021-01-01	2021-01-04	3,298	—	$0	0	SEC↗
Kay Mark A	Director	M Exercise deriv	2021-01-01	2021-01-04	2,199	—	$0	0	SEC↗
MOSCICKI RICHARD A	Director	M Exercise	2021-01-01	2021-01-04	3,916	—	$0	3,916	SEC↗
WYZGA MICHAEL S	Director	M Exercise	2021-01-01	2021-01-04	3,141	—	$0	3,141	SEC↗
Enyedy Mark J	Director	M Exercise	2021-01-01	2021-01-04	2,921	—	$0	2,921	SEC↗
	Director	M Exercise	2021-01-01	2021-01-04	3,298	—	$0	3,298	SEC↗
Kay Mark A	Director	M Exercise	2021-01-01	2021-01-04	2,199	—	$0	2,199	SEC↗
Goater Jeff	Director	A Award deriv	2020-12-10	2020-12-14	20,000	—	$0	20,000	SEC↗
Karydas Daphne	Director	A Award deriv	2020-12-10	2020-12-14	20,000	—	$0	20,000	SEC↗
O'Connell Daniel P	Director	M Exercise deriv	2020-12-10	2020-12-14	2,513	—	$0	0	SEC↗
O'Connell Daniel P	Director	M Exercise	2020-12-10	2020-12-14	2,513	—	$0	2,513	SEC↗
Nacht Mariana	Chief Scientific Officer	A Award deriv	2020-11-30	2020-12-01	200,000	—	$0	200,000	SEC↗
Chiang Kyle	Chief Operating Officer	A Award deriv	2020-11-02	2020-11-12	85,000	—	$0	85,000	SEC↗
Chimovits Erez	Director, 10% Owner	P Buy	2020-10-01	2020-10-05	296,296	$6.00	$1.78M	296,296	SEC↗
Chimovits Erez	Director, 10% Owner	P Buy	2020-10-01	2020-10-05	639,212	$6.00	$3.84M	4,126,972	SEC↗
Chimovits Erez	Director, 10% Owner	P Buy	2020-10-01	2020-10-05	545,974	$6.00	$3.28M	3,524,997	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2020-10-01	2020-10-05	545,974	$6.00	$3.28M	3,524,997	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2020-10-01	2020-10-05	296,296	$6.00	$1.78M	296,296	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	P Buy	2020-10-01	2020-10-05	639,212	$6.00	$3.84M	4,126,972	SEC↗
Arix Bioscience Holdings Ltd	10% Owner	S Sale	2020-09-28	2020-10-05	273,584	$7.54	$2.06M	2,381,436	SEC↗
Arix Bioscience Holdings Ltd	10% Owner	S Sale	2020-09-25	2020-10-05	174,219	$7.08	$1.23M	2,655,020	SEC↗
Arix Bioscience Holdings Ltd	10% Owner	S Sale	2020-09-24	2020-10-05	38,514	$7.63	$293.9K	2,829,239	SEC↗
Arix Bioscience Holdings Ltd	10% Owner	S Sale	2020-08-13	2020-10-05	159	$8.75	$1.4K	2,867,753	SEC↗
Arix Bioscience Holdings Ltd	10% Owner	S Sale	2020-08-12	2020-10-05	1,335	$8.79	$11.7K	2,867,912	SEC↗
Arix Bioscience Holdings Ltd	10% Owner	S Sale	2020-07-29	2020-10-05	2,709	$8.78	$23.8K	2,869,247	SEC↗
Arix Bioscience Holdings Ltd	10% Owner	S Sale	2020-07-22	2020-10-05	22,651	$9.00	$203.9K	2,871,956	SEC↗
Arix Bioscience Holdings Ltd	10% Owner	S Sale	2020-07-20	2020-10-05	36,983	$9.25	$342.1K	2,894,607	SEC↗
Arix Bioscience Holdings Ltd	10% Owner	S Sale	2020-07-17	2020-10-05	31,101	$9.24	$287.4K	2,931,590	SEC↗
Arix Bioscience Holdings Ltd	10% Owner	S Sale	2020-07-16	2020-10-05	16,332	$8.56	$139.8K	2,962,691	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2020-06-19	2020-06-23	3,141	—	$0	3,141	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2020-06-19	2020-06-23	10,000	—	$0	10,000	SEC↗
Chen Leon	Director	A Award deriv	2020-06-19	2020-06-23	10,000	—	$0	10,000	SEC↗
Chen Leon	Director	A Award deriv	2020-06-19	2020-06-23	3,298	—	$0	3,298	SEC↗
Kay Mark A	Director	A Award deriv	2020-06-19	2020-06-23	2,199	—	$0	2,199	SEC↗
Kay Mark A	Director	A Award deriv	2020-06-19	2020-06-23	10,000	—	$0	10,000	SEC↗
Enyedy Mark J	Director	A Award deriv	2020-06-19	2020-06-23	2,921	—	$0	2,921	SEC↗
Chimovits Erez	Director	A Award deriv	2020-06-19	2020-06-23	2,513	—	$0	2,513	SEC↗
Chimovits Erez	Director	A Award deriv	2020-06-19	2020-06-23	10,000	—	$0	10,000	SEC↗
O'Connell Daniel P	Director	A Award deriv	2020-06-19	2020-06-23	2,513	—	$0	2,513	SEC↗
O'Connell Daniel P	Director	A Award deriv	2020-06-19	2020-06-23	10,000	—	$0	10,000	SEC↗
MOSCICKI RICHARD A	Director	A Award deriv	2020-06-19	2020-06-23	3,916	—	$0	3,916	SEC↗
MOSCICKI RICHARD A	Director	A Award deriv	2020-06-19	2020-06-23	10,000	—	$0	10,000	SEC↗
Chereau Frederic	President and Chief Executiv	A Award deriv	2020-04-15	2020-04-17	23,414	—	$0	23,414	SEC↗
Yoon Seokho Bryan	Chief Admin Officer & GC	A Award deriv	2020-04-15	2020-04-17	17,445	—	$0	17,445	SEC↗
Jaffe Matthias	Chief Financial Officer	A Award deriv	2020-04-15	2020-04-17	17,218	—	$0	17,218	SEC↗
Enyedy Mark J	Director	A Award deriv	2020-03-17	2020-03-19	20,000	—	$0	20,000	SEC↗
Jaffe Matthias	Chief Financial Officer	A Award deriv	2020-02-11	2020-02-13	69,000	—	$0	69,000	SEC↗
Huttner Kenneth	SVP, Head of Clinical Dev.	A Award deriv	2020-02-11	2020-02-13	50,000	—	$0	50,000	SEC↗
Chereau Frederic	President and Chief Executiv	A Award deriv	2020-02-11	2020-02-13	222,000	—	$0	222,000	SEC↗
Yoon Seokho Bryan	Chief Admin Officer & GC	A Award deriv	2020-02-11	2020-02-13	95,000	—	$0	95,000	SEC↗
Kariv Tomer	Director	A Award deriv	2019-12-19	2019-12-20	10,869	—	$0	10,869	SEC↗
Chimovits Erez	Director	A Award deriv	2019-12-19	2019-12-20	10,869	—	$0	10,869	SEC↗
Chen Leon	Director	A Award deriv	2019-12-19	2019-12-20	10,869	—	$0	10,869	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2019-12-19	2019-12-20	10,869	—	$0	10,869	SEC↗
MOSCICKI RICHARD A	Director	A Award deriv	2019-12-19	2019-12-20	10,869	—	$0	10,869	SEC↗
O'Connell Daniel P	Director	A Award deriv	2019-12-19	2019-12-20	10,869	—	$0	10,869	SEC↗
Kay Mark A	Director	A Award deriv	2019-12-19	2019-12-23	10,869	—	$0	10,869	SEC↗
Yoon Seokho Bryan	Chief Admin Officer & GC	A Award deriv	2019-12-11	2019-12-13	110,000	—	$0	110,000	SEC↗
Wilton Thomas	Chief Business Officer	M Exercise deriv	2019-08-27	2019-08-29	75,000	—	$0	139,108	SEC↗
Wilton Thomas	Chief Business Officer	M Exercise	2019-08-27	2019-08-29	75,000	$0.73	$54.8K	75,000	SEC↗
Huttner Kenneth	SVP, Head of Clinical Dev.	A Award deriv	2019-02-20	2019-02-22	50,818	—	$0	50,818	SEC↗
Chimovits Erez	Director	C Conversion deriv	2018-10-23	2018-10-25	3,046,943	—	$0	0	SEC↗
Chimovits Erez	Director	C Conversion deriv	2018-10-23	2018-10-25	2,678,571	—	$0	0	SEC↗
O'Connell Daniel P	Director	C Conversion deriv	2018-10-23	2018-10-25	4,352,775	—	$0	0	SEC↗
Ioannidou Sofia	Director	C Conversion deriv	2018-10-23	2018-10-25	2,611,665	—	$0	0	SEC↗
Kariv Tomer	Director	C Conversion deriv	2018-10-23	2018-10-25	1,288,116	—	$0	692,982	SEC↗
Kariv Tomer	Director	C Conversion deriv	2018-10-23	2018-10-25	627,105	—	$0	0	SEC↗
Kariv Tomer	Director	C Conversion deriv	2018-10-23	2018-10-25	696,444	—	$0	328,339	SEC↗
OrbiMed Israel GP II, L.P.	Director, 10% Owner	C Conversion deriv	2018-10-23	2018-10-25	2,678,571	—	$0	0	SEC↗
OrbiMed Israel GP II, L.P.	Director, 10% Owner	C Conversion deriv	2018-10-23	2018-10-25	3,046,943	—	$0	2,279,023	SEC↗
OrbiMed Israel GP II, L.P.	Director, 10% Owner	C Conversion deriv	2018-10-23	2018-10-25	4,352,775	—	$0	0	SEC↗
Arix Bioscience plc	10% Owner	C Conversion deriv	2018-10-23	2018-10-26	4,352,775	—	$0	0	SEC↗
Chimovits Erez	Director	P Buy	2018-10-23	2018-10-25	490,000	$10.00	$4.90M	3,487,760	SEC↗
Chimovits Erez	Director	C Conversion	2018-10-23	2018-10-25	2,997,760	—	$0	2,997,760	SEC↗
O'Connell Daniel P	Director	P Buy	2018-10-23	2018-10-25	700,000	$10.00	$7.00M	2,979,023	SEC↗
O'Connell Daniel P	Director	C Conversion	2018-10-23	2018-10-25	2,279,023	—	$0	2,279,023	SEC↗
Ioannidou Sofia	Director	P Buy	2018-10-23	2018-10-25	420,000	$10.00	$4.20M	1,787,413	SEC↗
Ioannidou Sofia	Director	C Conversion	2018-10-23	2018-10-25	1,367,413	—	$0	1,367,413	SEC↗
Kariv Tomer	Director	C Conversion	2018-10-23	2018-10-25	674,431	—	$0	674,431	SEC↗
Kariv Tomer	Director	P Buy	2018-10-23	2018-10-25	100,849	$10.00	$1.01M	1,787,413	SEC↗
Kariv Tomer	Director	P Buy	2018-10-23	2018-10-25	112,000	$10.00	$1.12M	1,686,564	SEC↗
Kariv Tomer	Director	P Buy	2018-10-23	2018-10-25	207,151	$10.00	$2.07M	1,574,564	SEC↗
Kariv Tomer	Director	C Conversion	2018-10-23	2018-10-25	328,339	—	$0	1,367,413	SEC↗
Kariv Tomer	Director	C Conversion	2018-10-23	2018-10-25	364,643	—	$0	1,039,074	SEC↗
OrbiMed Israel GP II, L.P.	Director, 10% Owner	C Conversion	2018-10-23	2018-10-25	2,279,023	—	$0	5,276,783	SEC↗
OrbiMed Israel GP II, L.P.	Director, 10% Owner	C Conversion	2018-10-23	2018-10-25	2,997,760	—	$0	2,997,760	SEC↗
OrbiMed Israel GP II, L.P.	Director, 10% Owner	P Buy	2018-10-23	2018-10-25	490,000	$10.00	$4.90M	5,766,783	SEC↗
OrbiMed Israel GP II, L.P.	Director, 10% Owner	P Buy	2018-10-23	2018-10-25	700,000	$10.00	$7.00M	6,466,783	SEC↗
Arix Bioscience plc	10% Owner	P Buy	2018-10-23	2018-10-26	700,000	$10.00	$7.00M	2,979,023	SEC↗
Arix Bioscience plc	10% Owner	C Conversion	2018-10-23	2018-10-26	2,279,023	—	$0	2,279,023	SEC↗
MOSCICKI RICHARD A	Director	A Award deriv	2018-10-18	2018-10-22	24,102	—	$0	24,102	SEC↗
Jaffe Matthias	Chief Financial Officer	A Award deriv	2018-10-18	2018-10-22	95,293	—	$0	95,293	SEC↗
Kariv Tomer	Director	A Award deriv	2018-10-18	2018-10-22	24,102	—	$0	24,102	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2018-10-18	2018-10-22	24,102	—	$0	24,102	SEC↗
Chereau Frederic	President, CEO	A Award deriv	2018-10-18	2018-10-22	212,525	—	$0	212,525	SEC↗
Falb Dean	Chief Scientific Officer	A Award deriv	2018-10-18	2018-10-22	41,134	—	$0	41,134	SEC↗
Ioannidou Sofia	Director	A Award deriv	2018-10-18	2018-10-22	24,102	—	$0	24,102	SEC↗
Wilton Thomas	Chief Business Officer	A Award deriv	2018-10-18	2018-10-22	39,762	—	$0	39,762	SEC↗
Chen Leon	Director	A Award deriv	2018-10-18	2018-10-22	24,102	—	$0	24,102	SEC↗
Chimovits Erez	Director	A Award deriv	2018-10-18	2018-10-22	24,102	—	$0	24,102	SEC↗
Kay Mark A	Director	A Award deriv	2018-10-18	2018-10-22	24,102	—	$0	24,102	SEC↗
Poole Sandra	Chief Operating Officer	A Award deriv	2018-10-18	2018-10-22	106,262	—	$0	106,262	SEC↗
O'Connell Daniel P	Director	A Award deriv	2018-10-18	2018-10-22	24,102	—	$0	24,102	SEC↗
Wilton Thomas	Chief Business Officer	A Award deriv	2018-10-18	2018-10-24	29,000	—	$0	29,000	SEC↗
Falb Dean	Chief Scientific Officer	A Award deriv	2018-10-18	2018-10-24	30,000	—	$0	30,000	SEC↗
Jaffe Matthias	Chief Financial Officer	A Award deriv	2018-10-18	2018-10-24	69,500	—	$0	69,500	SEC↗
Poole Sandra	Chief Operating Officer	A Award deriv	2018-10-18	2018-10-24	77,500	—	$0	77,500	SEC↗
Chereau Frederic	President, CEO	A Award deriv	2018-10-18	2018-10-24	155,000	—	$0	155,000	SEC↗
FARKAS HOWARD L	Director	P Buy	2013-04-04	2013-04-17	25,000	$0.19	$4.8K	3,716,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2013-03-21	2013-04-17	30,000	$0.13	$3.9K	3,716,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2013-03-07	2013-04-17	30,000	$0.12	$3.6K	3,716,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2013-02-21	2013-04-17	30,000	$0.12	$3.6K	3,716,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2013-02-07	2013-04-17	35,000	$0.06	$2.1K	3,716,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2013-01-10	2013-04-17	45,000	$0.07	$3.2K	3,716,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2012-12-14	2013-01-07	1,025,000	$0.04	$41.0K	3,521,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2012-11-29	2013-01-07	400,000	$0.10	$40.0K	3,521,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2012-09-18	2013-01-07	200,000	$0.10	$20.0K	3,521,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2012-07-17	2012-09-13	100,000	$0.15	$15.0K	1,896,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2012-07-02	2012-09-13	107,143	$0.14	$15.0K	1,896,900	SEC↗
Stanley Robert	Director	P Buy	2012-05-14	2012-09-13	136,364	$0.22	$30.0K	1,520,772	SEC↗
FARKAS HOWARD L	Director	P Buy	2012-05-11	2012-09-13	136,364	$0.22	$30.0K	1,896,900	SEC↗
FARKAS HOWARD L	Director	P Buy	2012-04-30	2012-09-13	125,000	$0.20	$25.0K	1,896,900	SEC↗
Stanley Robert	Director	P Buy	2012-04-30	2012-09-13	125,000	$0.20	$25.0K	1,520,772	SEC↗
FARKAS HOWARD L	Director	P Buy	2012-02-09	2012-09-13	272,727	$0.22	$60.0K	1,896,900	SEC↗
Stanley Robert	Director	P Buy	2012-02-07	2012-09-13	272,727	$0.22	$60.0K	1,520,772	SEC↗
Stanley Robert	Director, 10% Owner	P Buy	2012-01-10	2012-01-26	500,000	$0.15	$75.0K	986,681	SEC↗
FARKAS HOWARD L	Director, 10% Owner	P Buy	2011-12-23	2012-01-26	200,000	$0.15	$30.0K	1,155,666	SEC↗
Stanley Robert	Director, 10% Owner	P Buy	2011-12-07	2012-01-26	138,889	$0.18	$25.0K	986,681	SEC↗
FARKAS HOWARD L	Director, 10% Owner	P Buy	2011-12-02	2012-01-26	230,769	$0.13	$30.0K	1,155,666	SEC↗
Stanley Robert	Director, 10% Owner	P Buy	2011-04-29	2012-01-26	33,333	$0.75	$25.0K	986,681	SEC↗